Noveltreat 0.25 mg Pre-filled Pen
Dosage
Starting at just
$61.59
In stock
Only %1 left
SKU
CMS8988
What is Noveltreat 0.25 mg Pre-filled Pen
Noveltreat 0.25 mg Pre-filled Pen is a once-weekly injectable medication containing the FDA-approved active ingredient Semaglutide base (0.25 mg/0.5 ml). It belongs to the class of medicines called Glucagon-like Peptide-1 (GLP-1) receptor agonists. Sun Pharmaceutical Industries Ltd manufactures Noveltreat pen in GMP-compliant facilities.
Its active ingredient, Semaglutide, mimics the action of the naturally occurring GLP-1 hormone. It stimulates insulin secretion in response to elevated blood sugar levels, suppresses glucagon release, and slows gastric emptying. These combined effects help regulate blood glucose levels while also reducing appetite.
Noveltreat is also used in the treatment of Obesity or overweight conditions, alongside diet and exercise, particularly in adults with weight-related health complications such as heart disease.
Each pre-filled pen delivers a pre-measured 0.25 mg dose and is designed for subcutaneous (under the skin) self-injection. The injection is typically administered once a week on the same day, into the abdomen, thigh, or upper arm.
A doctor usually guides on the correct injection technique and the appropriate site rotation. While usually well-tolerated, Semaglutide can cause common side effects, including nausea, vomiting, diarrhea, and constipation, especially during the initial weeks of treatment. These are usually mild and tend to diminish as your body adapts to the medication.
Inform the healthcare expert immediately in case of severe abdominal pain, signs of Pancreatitis, or any allergic reactions. Store this medication in a refrigerator between 2°C and 8°C and do not freeze it.
What are the benefits of taking Noveltreat 0.25 mg Pre-filled Pen
Noveltreat 0.25 mg Pre-filled Pen offers convenient management of blood sugar levels and body weight through a single weekly injection. The main benefits include:
- Blood sugar regulation: It stimulates insulin release when blood glucose is high and suppresses glucagon, helping maintain stable blood sugar levels throughout the week.
- Appetite control: Semaglutide reduces hunger signals by slowing gastric emptying, supporting lower calorie intake and sustained weight loss over time.
- Cardiovascular protection: Noveltreat is indicated for adults who are overweight or obese with established heart disease, helping reduce the risk of severe cardiovascular events.
- Gradual dose initiation: The 0.25 mg dose serves as a gentle introduction to Semaglutide therapy, minimizing gastrointestinal side effects during the adjustment period.
How to take Noveltreat 0.25 mg Pre-filled Pen
Noveltreat 0.25 mg Pre-filled Pen is a prescription medication. Always use it exactly as directed by the healthcare professional. The general guidelines are as follows:
- Administer the injection once a week, on the same day each week, at any time of day.
- Remove the Noveltreat pen from the refrigerator. Allow it to reach room temperature before injecting.
- Inject subcutaneously (under the skin) into the abdomen, thigh, or upper arm. Rotate the injection site to avoid swelling.
- You may take this injection with or without food. However, in the case of nausea, eat small, frequent, balanced meals and avoid greasy, high-fat foods.
- Do not take more than one dose in seven days or exceed the prescribed dosage. Do not self-administer without proper training.
Strengths and Substitutes
Noveltreat Pre-filled Pen is currently available in a single strength at Cheap Medicine Shop. However, the following effective alternatives are available:
| Wegovy 0.5 mg | $270.58/injection |
| Wegovy 0.25 mg | $270.58/injection |
| Wegovy 1 mg | $270.58/injection |
What are the side effects of Noveltreat 0.25 mg Pre-filled Pen
Like any medication, Noveltreat 0.25 mg Pre-filled Pen can cause side effects. Most are temporary and tend to subside as the body adjusts to the treatment. Common ones include:
- Nausea
- Vomiting
- diarrhea
- Constipation
- Abdominal discomfort
- Decreased appetite
- Headache
However, consult a healthcare professional if they persist or worsen.
Safety Advice
Liver Disease
Patients with mild to moderate liver conditions should use Noveltreat with caution. However, it is not recommended for those with severe liver conditions. Consult a doctor for a complete assessment before initiating treatment.
Kidney Impairment
Noveltreat 0.25 mg can generally be used in patients with mild to moderate renal impairment. Caution is advised in severe kidney disease, and regular monitoring of renal function is recommended throughout the course of therapy. Always consult a doctor before use to ensure safety.
Pregnant and Breastfeeding women
Noveltreat 0.25 mg is not recommended during pregnancy or breastfeeding. Women of childbearing age are advised to use contraception during treatment and for a period after stopping it. Always consult the doctor before use.
Avoid
Do not use Noveltreat if allergic to Semaglutide or any other ingredients. Avoid use in case of personal or family history of Medullary Thyroid Carcinoma (cancer inside thyroid gland) or Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2), which is a genetic condition that causes tumors in endocrine glands. Also, avoid driving in case of dizziness when using this medicine.
FAQs
What are the common side effects of Noveltreat 0.25 mg?
The most frequently reported side effects of Noveltreat 0.25 mg include nausea, vomiting, diarrhea, constipation, and reduced appetite. These are generally mild and most common during the first few weeks of treatment as your body adjusts. Staying hydrated and eating smaller, more frequent light meals can help manage these effects.
Can I take Noveltreat with other Diabetes medicines?
Yes, Noveltreat can be used alongside other antidiabetic medications, but only under medical supervision. When combined with insulin or sulphonylureas, the risk of Hypoglycemia (low blood sugar) increases, so your doctor may need to adjust the doses of your existing medicines accordingly.
Who should not use Noveltreat 0.25 mg?
Noveltreat 0.25 mg should not be used by people with a personal or family history of Medullary Thyroid Carcinoma. It is also contraindicated in those with known hypersensitivity to Semaglutide, those with Type 1 Diabetes, and individuals who are pregnant or breastfeeding without prior consultation with a doctor.
What should I do if I miss a dose of Noveltreat 0.25 mg?
If you miss your weekly dose and there are at least 2 days (48 hours) remaining before your next scheduled dose, take the missed Semaglutide dose as soon as you remember. If fewer than 2 days remain, skip the missed dose entirely and resume your regular weekly schedule.
How long does it take for Noveltreat to show results?
While some patients notice a reduction in appetite within the first few weeks, meaningful improvements in blood sugar control and body weight typically become apparent after 8-12 weeks of consistent use. Individual results can vary depending on diet, lifestyle, and the underlying condition being treated.
Can Noveltreat 0.25 mg be used for weight loss alone?
No, Noveltreat 0.25 mg should not be used for weight loss alone. While this Semaglutide pen is indicated for weight management in adults, it should always be paired with a reduced-calorie diet and increased physical activity, as directed by a healthcare professional.
Is it safe to drive while using Noveltreat 0.25 mg?
It is best to practice caution when driving if using Noveltreat. It can affect blood sugar levels, which can sometimes cause dizziness. If you notice such symptoms, it is best to avoid driving.
What's this?
Check "Remember Me" to access your shopping cart on this computer even if you are not signed in.